Research location

Hong Kong

Hong Kong

Published trials755

Site observations1,080

Linked trials published755

Page1 / 16

Research activity in Hong Kong

Hong Kong

CureCurrent currently publishes aggregate city-level research activity for this location: 755 trials and 1,080 site observations.

The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.

Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.

Trials with sites in Hong Kong

755 linked trials · page 1 of 16

Effects of Mental Imagery With Self-regulation on Daily Activities in People With Parkinson's DiseaseNCT07860294 · 2026-10-05 · 1 site observation

A Study to Evaluate the Efficacy and Safety of Divarasib Compared With Investigator's Choice of Immunotherapy or Observation in Participants With Resected Stage II-III KRAS G12C-Positive Non-Small Cell Lung Cancer (NSCLC)NCT07541170 · 2026-09-30 · 1 site observation

A Study to Investigate the Efficacy and Safety of Elecoglipron in Asian Participants With Obesity or Overweight With or Without Type 2 Diabetes MellitusNCT07775404 · 2026-08-21 · 1 site observation

Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung CancerNCT07476287 · 2026-07-02 · 2 site observations

The Effect of Dapagliflozin on Exercise and Cardiac Functional Status of Patients After Fontan ProcedureNCT07482943 · 2026-07-01 · 2 site observations

Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLCNCT07489066 · 2026-06-30 · 1 site observation

Artificial Intelligence-assisted MDS-UPDRS Assessment for Parkinson's DiseaseNCT07381751 · 2026-06-01 · 1 site observation

Feasibility Testing of the "MyGlucoCare" Smartphone App for Women With Gestational DiabetesNCT07372872 · 2026-05-01 · 1 site observation

A Clinical Study of MK-1084 With Other Treatments for Non-small Cell Lung Cancer (MK-3475-01F)NCT07286149 · 2026-04-30 · 1 site observation

Dyadic Management Intervention in Older People With Co-occurring Cognitive Impairment and Diabetes as a Supplementary Approach to Chronic Diseases Self-Management ProgramNCT07496359 · 2026-04-01 · 1 site observation

Personalized Antiemetic Regimen According to Patients' Pharmacogenetic ProfileNCT07455955 · 2026-03-31 · 1 site observation

MK-3475A±Calderasib (MK-1084) in Completely Resected Stage IIA-IIIB (N2) KRAS G12Cm NSCLC (MK-1084-013)NCT07431827 · 2026-03-18 · 2 site observations

Acupressure for Cough in Lung Cancer SurvivorsNCT07315672 · 2026-03-09 · 1 site observation

Local Ablative Therapy to Oligoresidual Metastasis in EGFR Mutated Non-small Cell Lung CancerNCT07379476 · 2026-02-11 · 1 site observation

Predictors of Clinical Outcomes of Deep Brain Stimulation in Parkinson's DiseaseNCT07376278 · 2026-02-05 · 1 site observation

Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD MutationsNCT07195695 · 2026-01-16 · 4 site observations

TulmiSTAR-02: A Phase I/II Open-label Study of Tulmimetostat in Combination With Darolutamide vs. Darolutamide, and Tulmimetostat With Abiraterone in Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)NCT07190300 · 2026-01-13 · 1 site observation

No Time to Wait: Single Session InterventionNCT07383467 · 2026-01-10 · 1 site observation

Impact of Chemotherapy Dose Reductions on Survival Outcomes Among Older NSCLC Patients Without Actionable MutationsNCT07369596 · 2026-01-01 · 1 site observation

KEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC) With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) G12C Mutations (MK-3475-01J/KEYMAKER-U01J)NCT07252739 · 2025-12-19 · 1 site observation

The Effectiveness of Tele-pulmonary Rehabilitation Program on People With Chronic Obstructive Pulmonary Disease (COPD) After Hospitalization for Acute ExacerbationNCT07762157 · 2025-12-01 · 1 site observation

DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard ChemoimmunotherapyNCT07472517 · 2025-11-07 · 1 site observation

International Severe Asthma Registry_Hong KongNCT07524543 · 2025-11-01 · 1 site observation

A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung CancerNCT06793215 · 2025-10-24 · 2 site observations

Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung CancerNCT06899126 · 2025-10-24 · 2 site observations

Hong Kong Diabesity Register & 3-Year Trial on Integrated Care for Chinese With DiabesityNCT07039279 · 2025-10-22 · 1 site observation

Establishment of Hong Kong Diabesity RegisterNCT07247409 · 2025-10-22 · 1 site observation

A PHASE I STUDY OF ALPS12 IN PATIENTS WITH EXTENSIVE STAGE SMALL CELL LUNG CANCERNCT07107490 · 2025-10-08 · 1 site observation

Mindful-Breath for People With COPDNCT07195838 · 2025-09-30 · 1 site observation

Two-fraction Proton Therapy With MRI Guidance for Prostate Cancer: A Phase II TrialNCT07130682 · 2025-09-01 · 1 site observation

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast CancerNCT06982521 · 2025-08-26 · 3 site observations

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or ObesityNCT07037433 · 2025-07-25 · 1 site observation

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular DiseaseNCT07064473 · 2025-07-22 · 4 site observations

A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)NCT07060807 · 2025-07-21 · 4 site observations

Transcranial Pulse Stimulation for Alzheimer's DiseaseNCT07143734 · 2025-07-21 · 1 site observation

Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLCNCT06765109 · 2025-07-17 · 2 site observations

ELEVATE-HFpEF Clinical StudyNCT06678841 · 2025-07-09 · 2 site observations

Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPCNCT06855277 · 2025-07-01 · 1 site observation

Prostate Irreversible Electroporation StudyNCT06886321 · 2025-06-30 · 1 site observation

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and ObesityNCT07037459 · 2025-06-25 · 1 site observation

Developing an AI Pharmacy Chatbot for the Population of Hong KongNCT07037563 · 2025-06-01 · 2 site observations

Validation of the CIDI 5.0 Against the SCID-5 for Lifetime Mental DisordersNCT07604753 · 2025-05-14 · 1 site observation

A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)NCT06925737 · 2025-05-13 · 1 site observation

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)NCT06881784 · 2025-05-06 · 2 site observations

A Study on COPD Phenotypes, Endotypes and Treatable TraitsNCT06952881 · 2025-05-02 · 1 site observation

Thoracic Surgery by the Medtronic Hugo™ Robotic SystemNCT06669104 · 2025-05-01 · 1 site observation

Glucokinase Activator in Monogenic DiabetesNCT06976658 · 2025-04-30 · 1 site observation

Randomised Clinical Trial to Investigate Efficacy and Safety of Benralizumab 30 mg SC as an add-on Therapy in Uncontrolled Eosinophilic Asthma Patients Treated With Medium-dose ICS-LABA Compared to Conventional Escalation to High-dose ICS-LABA TreatmentNCT06750289 · 2025-03-28 · 1 site observation

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)NCT06878261 · 2025-03-25 · 1 site observation

Effect of Semaglutide in Patients With Psoriasis and ObesityNCT06937060 · 2025-03-20 · 1 site observation

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.